DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION
作者： Frans van de Werf
DOI: 10.1016/S0140-6736(89)92812-2
关键词:
摘要: Les statistiques de survie a court et long terme fonction ventriculaire gauche apres traitement par thrombolyse l'infarctus aigu, meme execute tardivement, 12 24 h le debut des symptomes, montrent que les effets benefiques la reperfusion coronarienne ne dependent pas seulement recuperation du myocarde ischemique
sci-hub.se 参考文章(21)
R.G. Wilcox, C.G. Olsson, A.M. Skene, G. Von Der Lippe, G. Jensen, J.R. Hampton, For The Asset Study Group, TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) The Lancet. ,vol. 332, pp. 525- 530 ,(1988) , 10.1016/S0140-6736(88)92656-6
GRUPPOITALIANOPERLOSTUDIODELL, EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION The Lancet. ,vol. 327, pp. 397- 402 ,(1986) , 10.1016/S0140-6736(86)92368-8
M.L Simoons, M.V/D Brand, C.De Zwaan, F.W.A Verheugt, W.J Remme, P.W Serruys, F Bär, J Res, X.H Krauss, F Vermeer, J Lubsen, IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands The Lancet. ,vol. 326, pp. 578- 581 ,(1985) , 10.1016/S0140-6736(85)90584-7
Anti-basement-membrane antibodies in the serum of healthy subjects. The New England Journal of Medicine. ,vol. 314, pp. 1456- 1457 ,(1986) , 10.1056/NEJM198605293142219
GRUPPOITALIANOPERLOSTUDIODELL, LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY The Lancet. ,vol. 330, pp. 871- 874 ,(1987) , 10.1016/S0140-6736(87)91369-9
J W Kennedy, G V Martin, K B Davis, C Maynard, M Stadius, F H Sheehan, J L Ritchie, The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation. ,vol. 77, pp. 345- 352 ,(1988) , 10.1161/01.CIR.77.2.345
Thomas Meinertz, Wolfgang Kasper, Martin Schumacher, Hanjörg Just, The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. American Journal of Cardiology. ,vol. 62, pp. 347- 351 ,(1988) , 10.1016/0002-9149(88)90956-3
R NORRIS, THERAPEUTIC TRIALS IN CORONARY THROMBOSIS SHOULD MEASURE LEFT VENTRICULAR FUNCTION AS PRIMARY END-POINT OF TREATMENT The Lancet. ,vol. 331, pp. 104- 106 ,(1988) , 10.1016/S0140-6736(88)90295-4
F. Van de Werf, A. E. Arnold, Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. ,vol. 297, pp. 1374- 1379 ,(1988) , 10.1136/BMJ.297.6660.1374
J. Ward Kennedy, James L. Ritchie, Kathryn B. Davis, Michael L. Stadius, Charles Maynard, James K. Fritz, The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction New England Journal of Medicine. ,vol. 312, pp. 1073- 1078 ,(1985) , 10.1056/NEJM198504253121701